findmyKOL

Peter Fail, MD

Basic profile

Cardiovascular Institute of the South

ORCID↗NPI↗
✓ Full record
RegionHouma, LA · South CentralSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
Active KOLfindmyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Peter Fail is a Cardiology physician affiliated with Cardiovascular Institute of the South. OpenAlex indexes 88 publications with 7,058 citations (h-index 31).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
88publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,058citations

Total citations across indexed works.

31h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
31companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

225 Dunn St
Houma, LA 70360

Telephone

985-876-0300

Registry record last updated 5 Jul 2018.

View the NPPES registry record

Industry payments

31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.1%
    Statin17.8%
    Atorvastatin Calcium47%Rosuvastatin Calcium46%Pravastatin Sodium4%Simvastatin3%
    Part D≥376 patients
    Beta blocker13.2%
    Metoprolol Succinate62%Carvedilol15%Metoprolol Tartrate12%Atenolol3%Nebivolol Hcl3%Acebutolol Hcl2%Sotalol2%Nadolol1%Bisoprolol Fumarate1%
    Part D<11 patients

    + 26 more classes in this area

  • Blood & clotting

    9.8%
    P2Y12 inhibitor4.7%
    Clopidogrel97%Brilinta2%Prasugrel Hcl2%
    Part D<11 patients
    Factor Xa inhibitor3.5%
    Eliquis77%Xarelto23%
    Part D≥110 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    8.4%
    SGLT2 inhibitor6.7%
    Jardiance86%Farxiga14%
    Part D≥223 patients
    Proton pump inhibitor1.1%
    Pantoprazole Sodium61%Esomeprazole Magnesium20%Omeprazole19%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0.4% facility · 99.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”